(DEL) Delko S.A. - Ratings and Ratios
Household Chemicals, Cosmetics, Industrial Products, Hygiene Products, Food
Description: DEL Delko S.A.
Delko S.A. is a Polish company that operates in the distribution and retail of household chemicals, cosmetics, and food products, leveraging a multi-channel approach that includes wholesale, retail stores, and e-commerce. The companys diversified product portfolio and extensive distribution network enable it to cater to a broad customer base, including retail chains, wholesalers, and individual consumers. With a presence in the Polish market since 1995, Delko S.A. has established a significant footprint, with a franchise retail network that further expands its reach.
Analyzing the companys market presence and financials, its clear that Delko S.A. operates within a competitive landscape. The Personal Care Products sub-industry is characterized by high competition and evolving consumer preferences. Delkos engagement in both wholesale and retail, along with its e-commerce platform, positions it relatively well to adapt to market shifts. However, the companys Return on Equity (RoE) of 3.54% indicates that it may be facing challenges in generating profits from shareholders equity, suggesting a need for either operational improvements or strategic adjustments to enhance profitability.
From a technical analysis perspective, Delko S.A.s stock (WAR:DEL) is currently priced at 6.80 PLN, below its short-term (SMA20: 6.95 PLN) and longer-term moving averages (SMA50: 7.26 PLN, SMA200: 7.82 PLN), indicating a downtrend. The Average True Range (ATR) of 0.16 PLN or 2.35% suggests moderate volatility. Given the 52-week high and low prices (8.82 PLN and 6.68 PLN, respectively), the stock is near its 52-week low, potentially signaling a point of support or a value buying opportunity if fundamentals are strong.
Forecasting the future performance of Delko S.A. involves integrating both technical and fundamental analyses. While the technical indicators suggest a downtrend, the proximity to the 52-week low could indicate a potential reversal or stabilization if buying interest emerges. Fundamentally, a P/E ratio of 15.13 suggests that the stock might be relatively undervalued or fairly valued compared to industry peers, depending on the sectors average P/E. However, the absence of a forward P/E ratio complicates the earnings growth outlook. Given these factors, a cautious outlook is warranted. If Delko S.A. can improve its RoE and demonstrate stable or growing earnings, the stock might see a positive revaluation. Conversely, failure to address profitability concerns could lead to further downward pressure on the stock price. As of now, a neutral to slightly bullish stance could be considered, with a close eye on future earnings announcements and industry trends.
DEL Stock Overview
Market Cap in USD | 22m |
Sub-Industry | Personal Care Products |
IPO / Inception |
DEL Stock Ratings
Growth Rating | -19.6% |
Fundamental | 46.1% |
Dividend Rating | 79.8% |
Return 12m vs S&P 500 | -23.9% |
Analyst Rating | - |
DEL Dividends
Dividend Yield 12m | 11.79% |
Yield on Cost 5y | 10.99% |
Annual Growth 5y | 31.95% |
Payout Consistency | 60.7% |
Payout Ratio | 11.5% |
DEL Growth Ratios
Growth Correlation 3m | -15.9% |
Growth Correlation 12m | -75.8% |
Growth Correlation 5y | 54.8% |
CAGR 5y | -2.57% |
CAGR/Max DD 5y | -0.04 |
Sharpe Ratio 12m | -0.19 |
Alpha | -20.54 |
Beta | 0.440 |
Volatility | 26.49% |
Current Volume | 3.2k |
Average Volume 20d | 1.8k |
Stop Loss | 6.4 (-3.6%) |
Signal | -0.78 |
Piotroski VR‑10 (Strict, 0-10) 5.5
Net Income (5.12m TTM) > 0 and > 6% of Revenue (6% = 48.3m TTM) |
FCFTA 0.07 (>2.0%) and ΔFCFTA 1.62pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 5.08% (prev 5.44%; Δ -0.36pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.08 (>3.0%) and CFO 28.1m > Net Income 5.12m (YES >=105%, WARN >=100%) |
Net Debt (27.9m) to EBITDA (9.79m) ratio: 2.85 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.28 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (12.0m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
Gross Margin 21.79% (prev 21.03%; Δ 0.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 235.5% (prev 260.0%; Δ -24.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 2.10 (EBITDA TTM 9.79m / Interest Expense TTM 4.67m) >= 6 (WARN >= 3) |
Altman Z'' 3.06
(A) 0.12 = (Total Current Assets 187.5m - Total Current Liabilities 146.6m) / Total Assets 337.6m |
(B) 0.40 = Retained Earnings (Balance) 135.9m / Total Assets 337.6m |
(C) 0.03 = EBIT TTM 9.79m / Avg Total Assets 341.5m |
(D) 0.73 = Book Value of Equity 135.9m / Total Liabilities 187.1m |
Total Rating: 3.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.07
1. Piotroski 5.50pt = 0.50 |
2. FCF Yield 23.56% = 5.0 |
3. FCF Margin 3.14% = 0.78 |
4. Debt/Equity 0.36 = 2.44 |
5. Debt/Ebitda 5.52 = -2.50 |
6. ROIC - WACC -1.43% = -1.78 |
7. RoE 3.30% = 0.27 |
8. Rev. Trend -65.66% = -3.28 |
9. Rev. CAGR -3.82% = -0.64 |
10. EPS Trend -89.00% = -2.22 |
11. EPS CAGR -61.19% = -2.50 |
What is the price of DEL shares?
Over the past week, the price has changed by +0.00%, over one month by -3.21%, over three months by -5.14% and over the past year by -10.94%.
Is Delko S.A. a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DEL is around 6.97 PLN . This means that DEL is currently overvalued and has a potential downside of 4.97%.
Is DEL a buy, sell or hold?
What are the forecasts/targets for the DEL price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7.6 | 13.7% |
DEL Fundamental Data Overview
Market Cap PLN = 79.2m (79.2m PLN * 1.0 PLN.PLN)
CCE Cash And Equivalents = 26.1m PLN (Cash only, last quarter)
P/E Trailing = 15.3953
P/S = 0.0984
P/B = 0.5293
Beta = 0.265
Revenue TTM = 804.5m PLN
EBIT TTM = 9.79m PLN
EBITDA TTM = 9.79m PLN
Long Term Debt = unknown (0.0)
Short Term Debt = 54.0m PLN (from shortLongTermDebt, last quarter)
Debt = 54.0m PLN (Calculated: Short Term 54.0m + Long Term 0.0)
Net Debt = 27.9m PLN (from netDebt column, last quarter)
Enterprise Value = 107.1m PLN (79.2m + Debt 54.0m - CCE 26.1m)
Interest Coverage Ratio = 2.10 (Ebit TTM 9.79m / Interest Expense TTM 4.67m)
FCF Yield = 23.56% (FCF TTM 25.2m / Enterprise Value 107.1m)
FCF Margin = 3.14% (FCF TTM 25.2m / Revenue TTM 804.5m)
Net Margin = 0.64% (Net Income TTM 5.12m / Revenue TTM 804.5m)
Gross Margin = 21.79% ((Revenue TTM 804.5m - Cost of Revenue TTM 629.1m) / Revenue TTM)
Tobins Q-Ratio = 0.79 (Enterprise Value 107.1m / Book Value Of Equity 135.9m)
Interest Expense / Debt = 2.39% (Interest Expense 1.29m / Debt 54.0m)
Taxrate = 17.56% (from yearly Tax Provision: 3.24m / 18.5m)
NOPAT = 8.07m (EBIT 9.79m * (1 - 17.56%))
Current Ratio = 1.28 (Total Current Assets 187.5m / Total Current Liabilities 146.6m)
Debt / Equity = 0.36 (Debt 54.0m / last Quarter total Stockholder Equity 150.5m)
Debt / EBITDA = 5.52 (Net Debt 27.9m / EBITDA 9.79m)
Debt / FCF = 2.14 (Debt 54.0m / FCF TTM 25.2m)
Total Stockholder Equity = 155.2m (last 4 quarters mean)
RoA = 1.52% (Net Income 5.12m, Total Assets 337.6m )
RoE = 3.30% (Net Income TTM 5.12m / Total Stockholder Equity 155.2m)
RoCE = 6.31% (Ebit 9.79m / (Equity 155.2m + L.T.Debt 0.0))
RoIC = 3.91% (NOPAT 8.07m / Invested Capital 206.3m)
WACC = 5.34% (E(79.2m)/V(133.2m) * Re(7.64%)) + (D(54.0m)/V(133.2m) * Rd(2.39%) * (1-Tc(0.18)))
Shares Correlation 5-Years: -70.70 | Cagr: -0.04%
Discount Rate = 7.64% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 80.22% ; FCFE base≈23.2m ; Y1≈26.8m ; Y5≈37.7m
Fair Price DCF = 54.47 (DCF Value 651.4m / Shares Outstanding 12.0m; 5y FCF grow 17.91% → 3.0% )
Revenue Correlation: -65.66 | Revenue CAGR: -3.82%
Rev Growth-of-Growth: -15.65
EPS Correlation: -89.00 | EPS CAGR: -61.19%
EPS Growth-of-Growth: -27.26